IL-21-induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses

Journal of Experimental Medicine

Volumn 203, Issue 13, 2006, Pages 2929-2937

  Harada, Michishige ^a   Magara Koyanagi, Kumiko ^b   Watarai, Hiroshi ^a   Nagata, Yuko ^a   Ishii, Yasuyuki ^a   Kojo, Satoshi ^a   Horiguchi, Shigetoshi ^b   Okamoto, Yoshitaka ^b   Nakayama, Toshinori ^b   Suzuki, Nobutaka ^a   Yeh, Wen Chen ^c   Akira, Shizuo ^d   Kitamura, Hiroshi ^a   Ohara, Osamu ^a   Seino, Ken Ichiro ^a   Taniguchi, Masaru ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN E; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; PROTEIN BCL 2;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIGENS, CD1; APOPTOSIS; B-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-12; INTERLEUKINS; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MONOCYTES, ACTIVATED KILLER; MYCOBACTERIUM BOVIS; OVALBUMIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 33845903869     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062206     Document Type: Article

References (52)

1. Umetsu, D.T., J.J. Mcintire, O. Akbari, C. Macaubas, and R.H. Dekruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
2. Cookson, W.O., and M.F. Moffatt. 1997. Asthma: an epidemic in the absence of infection? Science. 275:41-42.
3. Von Mutius, E. 2000. The environmental predictors of allergic disease. J. Allergy Clin. Immunol. 105:9-19.
4. Shaheen, S.O., P. Aaby, A.J. Hall, D.J. Barker, C.B. Heyes, A.W. Shiell, and A. Goudiaby. 1996. Measles and atopy in Guinea-Bissau. Lancet. 347:1792-1796.
5. Shirakawa, T., T. Enomoto, S. Shimazu, and J.M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder. Science. 275:77-79.
6. Adams, J.F., E.H. Scholvinck, R.P. Gie, P.C. Potter, N. Beyers, and A.D. Beyers. 1999. Decline in total serum IgE after treatment for tuberculosis. Lancet. 353:2030-2033.
7. Herz, U., K. Gerhold, C. Gruber, A. Braun, U. Wahn, H. Renz, and K. Paul. 1998. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J. Allergy Clin. Immunol. 102:867-874.
8. Wang, C.C., and G.A. Rook. 1998. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology. 93:307-313.
9. Yang, X., S. Wang, Y. Fan, and L. Zhu. 1999. Systemic mycobacterial infection inhibits antigen-specific immunoglobulin E production, bronchial mucus production and eosinophilic inflammation induced by allergen. Immunology. 98:329-337.
10. Cavallo, G.P., M. Elia, D. Giordano, C. Baldi, and R. Cammarota. 2002. Decrease of specific and total IgE levels in allergic patients after BCG vaccination: preliminary report. Arch. Otolaryngol. Head Neck Surg. 128:1058-1060.
11. Krieg, A.M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760.
12. Renz, H., and U. Herz. 2002. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur. Respir. J. 19:158-171.
13. Akbari, O., P. Stock, R.H. Dekruyff, and D.T. Umetsu. 2003. Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 15:627-633.
14. Stassen, M., H. Jonuleit, C. Muller, M. Klein, C. Richter, T. Bopp, S. Schmitt, and E. Schmitt. 2004. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J. Immunol. 173:267-274.
15. Robinson, D.S., M. Larche, and S.R. Durham. 2004. Tregs and allergic disease. J. Clin. Invest. 114:1389-1397.
16. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483-513.
17. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190:783-792.
18. Suto, A., H. Nakajima, K. Hirose, K. Suzuki, S. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D.C. Foster, and I. Iwamoto. 2002. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood. 100:4565-4573.
19. Wood, N., K. Bourque, D.D. Donaldson, M. Collins, D. Vercelli, S.J. Goldman, and M.T. Kasaian. 2004. IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell. Immunol. 231:133-145.
20. Parrish-Novak, J., S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 408:57-63.
21. Parrish-Novak, J., D.C. Foster, R.D. Holly, and C.H. Clegg. 2002. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72:856-863.
22. Habib, T., A. Nelson, and K. Kaushansky. 2003. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 112:1033-1045.
23. Ozaki, K., R. Spolski, C.G. Feng, C.F. Qi, J. Cheng, A. Sher, H.C. Morse III, C. Liu, P.L. Schwartzberg, and W.J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science. 298:1630-1634.
24. Purkerson, J.M., and P.C. Isakson. 1994. Independent regulation of DNA recombination and immunoglobulin (Ig) secretion during isotype switching to IgG1 and IgE. J. Exp. Med. 179:1877-1883.
25. Mehta, D.S., A.L. Wurster, M.J. Whitters, D.A. Young, M. Collins, and M.J. Grusby. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:4111-4118.
26. Jin, H., R. Carrio, A. Yu, and T.R. Malek. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173:657-665.
27. Nelde, A., M. Teufel, C. Hahn, A. Duschl, W. Sebald, E.B. Brocker, and S.M. Grunewald. 2001. The impact of the route and frequency of antigen exposure on the IgE response in allergy. Int. Arch. Allergy Immunol. 124:461-469.
28. Gould, H.J., B.J. Sutton, A.J. Beavil, R.L. Beavil, N. Mccloskey, H.A. Coker, D. Fear, and L. Smurthwaite. 2003. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21:579-628.
29. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166:6012-6018.
30. Yoshimoto, T., A. Bendelac, C. Watson, J. Hu-Li, and W.E. Paul. 1995. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science. 270:1845-1847.
31. Brigl, M., L. Bry, S.C. Kent, J.E. Gumperz, and M.B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4:1230-1237.
32. Tsuji, S., M. Matsumoto, O. Takeuchi, S. Akira, I. Azuma, A. Hayashi, K. Toyoshima, and T. Seya. 2000. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 68:6883-6890.
33. Snapper, C.M., P. Zelazowski, F.R. Rosas, M.R. Kehry, M. Tian, D. Baltimore, and W.C. Sha. 1996. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:183-191.
34. Puthalakath, H., A. Villunger, L.A. O'Reilly, J.G. Beaumont, L. Coultas, R.E. Cheney, D.C. Huang, and A. Strasser. 2001. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 293:1829-1832.
35. Corrigan, C.J., and A.B. Kay. 1990. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141:970-977.
36. Hansen, G., G. Berry, R.H. Dekruyff, and D.T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175-183.
37. Arikan, C., N.N. Bahceciler, G. Deniz, M. Akdis, T. Akkoc, C.A. Akdis, and I.B. Barlan. 2004. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin. Exp. Allergy. 34:398-405.
38. Vargas, M.H., D.A. Bernal-Alcantara, M.A. Vaca, F. Franco-Marina, and R. Lascurain. 2004. Effect of BCG vaccination in asthmatic school-children. Pediatr. Allergy Immunol. 15:415-420.
39. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
40. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895-1903.
41. Apostolou, I., Y. Takahama, C. Belmant, T. Kawano, M. Huerre, G. Marchal, J. Cui, M. Taniguchi, H. Nakauchi, J.J. Fournie, et al. 1999. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA. 96:5141-5146.
42. Fischer, K., E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S.H. Kaufmann, and U.E. Schaible. 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA. 101:10685-10690.
43. Feinberg, J., C. Fieschi, R. Doffinger, M. Feinberg, T. Leclerc, S. Boisson-Dupuis, C. Picard, J. Bustamante, A. Chapgier, O. Filipe-Santos, et al. 2004. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur. J. Immunol. 34:3276-3284.
44. Darieva, Z., E.B. Lasunskaia, M.N. Campos, T.L. Kipnis, and W.D. Da Silva. 2004. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding. J. Leukoc. Biol. 75:689-697.
45. Nicolle, D., C. Fremond, X. Pichon, A. Bouchot, I. Maillet, B. Ryffel, and V.J. Quesniaux. 2004. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect. Immun. 72:6994-7004.
46. Kasaian, M.T., M.J. Whitters, L.L. Carter, L.D. Lowe, J.M. Jussif, B. Deng, K.A. Johnson, J.S. Witek, M. Senices, R.F. Konz, et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity. 16:559-569.
47. Hecker, M., A. Bohnert, I.R. Konig, G. Bein, and H. Hackstein. 2003. Novel genetic variation of human interleukin-21 receptor is associated with elevated IgE levels in females. Genes Immun. 4:228-233.
48. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
49. Suzuki, N., S. Suzuki, G.S. Duncan, D.G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:750-756.
50. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451.
51. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:143-150.
52. Harada, M., K. Seino, H. Wakao, S. Sakata, Y. Ishizuka, T. Ito, S. Kojo, T. Nakayama, and M. Taniguchi. 2004. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int. Immunol. 16:241-247.